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Diversity-oriented synthesis of star-shaped 2H-imidazolines
In recent years the importance of protein–protein interactions
(PPIs) as key mediators of cellular processes has become very
apparent. Furthermore, many of these PPIs are critical to the
etiology and progression of disease, and as such they provide
attractive intervention points for new drugs. However, many PPIs
are characterised by ﬂat and somewhat featureless interaction sur-
faces, and disrupting such interactions with most small Lipinski
‘Rule of 5’-compliant molecules has proven difﬁcult. An exception
to this has been the success observed with imidazolines, a class of
small but highly functionalised molecules that have demonstrated
an ability to interact with otherwise refractory drug targets.
One such example is the 1H-imidazoline compound Nutlin-3
(1), which is a potent binder to the cancer target MDM-2, and inhi-
bits the interaction with p53. A recent paper describes a highly
effective synthetic approach to diversely substituted analogues of
the ‘star-shaped’ related 2H-imidazoline class of compound [1].
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The particular advantage of this class of molecule is its pronounced
sp3 character, giving an advantageous three-dimensional aspect to
the molecules. In addition, many of the atoms in the ring can be
substituted giving up to ﬁve positions of diversity, and the two ring
nitrogen atoms aid solubility. The new publication devised a versa-
tile synthetic route that allows the preparation of diverse 2H-imida-
zolines commencing with a 1,2-diketone (3) that was subsequentlyderivatised by a three-component Debus-Radziszewski reaction.
The 1,2-ketones were readily prepared from an alkyne precursor
(2) assembled using Sonogashira couplings, and oxidation of the
alkyne proceeded efﬁciently for most substrates using potassium
permanganate as the oxidant.
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With the 1,2-diketones available, 2H-imidazoles (4) could be pre-
pared by the Debus-Radziszewski reaction, in which condensation
with a ketone proceeded in the presence of ammonium acetate.
These intermediates then could be reduced to 2H-imidazolines (5)
under a variety of conditions, but in general, it was found that
lithium aluminium hydride or hydrogenation over palladium-
carbon catalyst provided the best results. It was also found that
the 2H-imidazolines were unstable and over time would gently
re-oxidise to the 2H-imidazoles (4).
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tional groups onto the 2H-imidazoline nitrogen. A variety of meth-
ods including amide-, allyl-, carbamate- and urea-forming reactions
were performed, providing a diverse set of ﬁnal compounds (e.g. 6
and 7). In this way a library of 21 ‘star-shaped’ 2H-imidazolines was
prepared, representing an interesting chemotype with potential for
biological screening.
A summary of the papers in this month’s issue
Polymer supported synthesis
No papers this month.
Solution-phase synthesis
A straightforward one-pot preparation of a library of quinoxali-
nes from 2-nitroanilines under entirely metal-free conditions has
been described. Initial reduction of nitroaniline with hydrazine
hydrate was efﬁciently catalysed by graphene oxide (GO) or
reduced graphene oxide (rGO), and further one-pot tandem reac-
tions with 1,2-dicarbonyl compounds or with a-hydroxy ketones
afforded quinoxalines in excellent yields. The catalyst was recov-
ered, characterised, and found to be recyclable for consecutive four
runs [2].
A facile and efﬁcient synthetic route to arylpyridines has been
reported. When heated with boronic acids in the presence of
5 mol% PdCl2(PPh3)2 and KHCO3 in 4:1 DMF/H2O solution at
110 C, 5-iodopyridines underwent Suzuki–Miyaura coupling reac-
tions to afford 5-aryl-substituted pyridines in good to excellent
yields. This coupling approach could accommodate various func-
tional groups and provide rapid access to a library of functionalised
arylpyridines of pharmacological interest [3].
A variety of natural product- inspired pyrano-carbazole
derivatives have been assembled via hetero-Diels–Alder reaction
and Fischer indolisation under operationally simple reaction condi-
tions. The scope of this methodology has been expanded through
Suzuki–Miyaura cross-coupling reactions involving different boro-
nic acids. This simple strategy could be useful to generate a variety
of medicinally important carbazole derivatives [4].
An efﬁcient, one-pot, four-component procedure for the synthe-
sis of a small library of novel chiral spiro-indenoquinoxaline pyrro-
lidines and chiral spiro-indenoquinoxaline pyrrolizidines with high
regio-, diastereo-, and enantioselectivity, through a 1,3-dipolar
cycloaddition reaction of azomethine ylides and an optically active
cinnamoyl–crotonyl oxazolidinone has been described. The
methodology carried out in aqueous ethanol was simple and was
utilised to construct complex products from simple starting
materials [5].
Scaffolds and synthons for combinatorial libraries
Diversity-oriented concise asymmetric syntheses of l-2,3-trans-
3,4-cis-dihydroxyproline and (3S,5S)-3,4,5-trihydroxypiperidine
have been developed from (R)-glycidol. The key step of the synthe-
sis is Sharpless asymmetric dihydroxylation on an enantiomeri-
cally pure TBDMS-protected allylic alcohol which generated a
triol intermediate in excellent diastereoisomeric excess. The
(2R,3R,4S)-2,3-dihydroxypentanoate derivative was subsequently
converted to a natural pyrrolidine azasugar and a non-natural
piperidine azasugar in good yields [6].
Substituted pyridazine-3,6-diamines are attractive but poorly
precedented scaffolds in medicinal chemistry and are challenging
targets in terms of synthetic tractability. The use of a Buchwald
protocol for the facile synthesis of 4-aryl and alkyl substituted,
N6-alkylated pyridazine-3,6-diamines has recently been reported.This approach utilises the unreactive nature of the pyridazine
3-amino group, negating the need for an additional protecting
group in the transformation [7].
The triazine scaffold occupies a prominent position, possessing
a broad range of biological activities, and is found in many potent
biologically active molecules with promising anti-inﬂammatory,
anti-mycobacterial, anti-viral, and anti-cancer activities. This
makes it an attractive scaffold for the design and development of
new drugs. A recent review has compiled and discussed the biolog-
ical potential of triazine-derived compounds for the medicinal
chemist [8].
Solid-phase supported reagents
Imidazolidine-4-one derivatives have been anchored by the
thiol-ene click reaction to a swellable pearl-like polystyrene
copolymer and their complexes with Cu(II) acetate have been uti-
lised as recyclable heterogeneous catalysts for the Henry reaction
of substituted aldehydes with nitromethane. The corresponding
2-nitroethanols were mostly obtained in high yields (65–99%)
and with enantioselectivities of up to 92% ee [9].
A heterogeneous copper-catalysed direct oxidative cross-dehy-
drogenative coupling of terminal alkynes with thiols has been
achieved in DMSO at 70 C in the presence of an MCM-41-sup-
ported bidentate nitrogen copper(I) complex. Running the reaction
with K2CO3 under an atmosphere of oxygen, selectively gave a vari-
ety of alkynyl sulphides in good to excellent yields. This heteroge-
neous copper catalyst can be easily recovered by a simple ﬁltration
and recycled 10 times without any decreases in activity [10].
The preparation and characterisation of a heterogeneous recy-
clable catalyst based on Cu(II) complex of magnetic nanoparticles
Fe3O4SiO2 with (2R,5S)-5-isopropyl-5-methyl-2-(pyridine-2-yl)
imidazolidine-4-one has been described. The ligand molecules
were attached to the surface by means of coordination bonds,
and the catalyst characterised using DLS, FT-IR spectroscopy,
SEM, and microanalysis. The reaction of substituted aldehydes
with nitromethane catalysed with this complex proceeded with
high yields (82–99%) and high enantioselectivity (68–94%) [11].
Novel resins, linkers and techniques
A new methodology for the solid phase submonomer synthesis
(SPSS) of arylopeptoids using a reductive amination reaction as the
key step has been described. This contrasts with a nucleophilic
substitution reaction, which is generally used in conventional SPSS
of peptoids. The new SPSS enables easy access to arylopeptoid
oligomers in which phenyl side groups are directly attached to
the aromatic main chain [12].
Library applications
A series of sixteen hitherto unknown Cytarabine analogues
bearing a bicyclic 3H-pyrrolo[2,3-d]pyrimidin-2(7H)-one base
modiﬁed with aryl, pyridyl, benzyl and alkyl substituents have
been prepared by a straightforward approach. The conversion of
the furopyrimidine arabinoside products to a series of novel
pyrrolopyrimidines by ammonolysis reaction was thoroughly
investigated using aqueous and methanolic reaction conditions
under classical and micro-wave heating. This approach resulted
in a small library of compounds, which were evaluated for their
antiproliferative properties against HL-60 and Jurkat E6.1 cell lines
[13].
A mixture-based combinatorial library of ﬁve Ugi adducts incor-
porating known antitubercular and antimalarial pharmacophores
was successfully synthesised, starting from a naturally occurring
diisocyanide, via parallel Ugi four-centre three-component
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were evaluated for their antiinfective potential against laboratory
strains of Mycobacterium tuberculosis H37Rv and chloroquine-
susceptible 3D7 Plasmodium falciparum [14].
A novel series of spirocyclic-diamine based, isoform non-
selective inhibitors of acetyl-CoA carboxylase (ACC) have been
described. These spirodiamine derivatives were discovered by
design of a library to mimic the structural rigidity and hydrogen-
bonding pattern observed in the co-crystal structure of a
spirochromanone inhibitor. The best compound discovered inhib-
ited de novo lipogenesis in rat hepatocytes, with an IC50 of
0.30 lM [15].
Phenoxodiol, an analogue of the isoﬂavone natural product
daidzein, is a potent anti-cancer agent that has been investigated
for the treatment of hormone dependent cancers. This molecular
scaffold has been reacted with different primary amines and
secondary amines under various Mannich conditions to yield
either benzoxazine or aminomethyl substituted analogues. The
resulting Mannich bases exhibited prominent anti-proliferative
effects against SHEP neuroblastoma and MDA-MB-231 breast ade-
nocarcinoma cell lines. Further cytotoxicity studies against MRC-5
normal lung ﬁbroblast cells showed that the isoﬂavene analogues
were selective towards cancer cells [16].
In search of new chemical scaffolds to target breast cancer, a
phenotypic screen against the human breast carcinoma cell lines
MDA-MB-231, MA11, and MCF-7 using terrestrial natural products
was undertaken. Natural products, in particular the abietanes, that
preferentially inhibited proliferation of triple-negative MDA-
MB-231 cells over estrogen receptor–positive cells, were further
studied. The activity of the abietane carnosol prompted the gener-
ation of a focussed library from readily available (+)-dehydroabi-
etylamine [17].
DNA topoisomerase I is a potential chemotherapeutic target. A
library comprising of hydantoin and thiohydantoin derivatives
has been synthesised and tested against human and Leishmania
topoisomerase 1 (Top1). One of the thiohydantoin compounds
with substituted thiophenyl as the central moiety exhibited potent
inhibition of human Top1 through stabilization of Top1-DNA cleav-
age complexes and showed selective anticancer activity against
human cervical carcinoma (HeLa) and breast carcinoma (MCF-7)
cell lines [18].
A series of 3-piperidin-4-yl-1H-indoles with building block
diversity has been synthesised based on a hit derived from an
HTS whole-cell screen against Plasmodium falciparum. Thirty-eight
compounds were obtained following a three-step synthetic
approach and evaluated for anti-parasitic activity. A new com-
pound with lead-like properties, showing antimalarial activity
against drug-resistant and sensitive strains, selectivity for malaria
parasite and no cross-resistance with chloroquine was discovered
[19].
The antibiotic activity spectrum of the proline-rich antimicro-
bial peptide apidaecin, originally isolated from honeybees, has
been extended to further human pathogens including Pseudomonas
aeruginosa. However, the in vitro activity of the optimised peptide
Api137 is limited to diluted medium conditions. 323 analogs of
Api137 have been prepared on cellulose membranes using the
SPOT strategy, substituting each residue individually by 19 other
amino acids or deleting the residue. The 19 best peptides were syn-
thesised on a larger scale and puriﬁed and screened against various
bacterial strains [20].
Class B G protein-coupled receptors are activated by their
cognate ligands following a two-step binding model involving a
speciﬁc network of ligand-receptor intermolecular interactions.
The aim of a recent study was to implement the use of
Pd-catalysed Sonogashira coupling for the investigation of theN-capping structure present in peptide ligands. Various Sono-
gashira-based procedures were investigated for on-resin post-syn-
thesis modiﬁcation using a Leu-enkephalin derivative as a model
peptide. Following that, a small library of pituitary adenylate
cyclase-activating polypeptide-based analogues was prepared
and their pharmacological proﬁle obtained using a competitive
binding assay, as well as functional and survival assays [21].References
[1] Yu X, Guttenberger N, Fuchs E, Peters M, Weber H, Breinbauer R. Diversity-
oriented synthesis of a library of star-shaped 2H-imidazolines. ACS Comb Sci
2015;17(11):682–90.
[2] Roy B, Ghosh S, Ghosh P, Basu B. Graphene oxide (GO) or reduced graphene oxide
(rGO): eﬃcient catalysts for one-pot metal-free synthesis of quinoxalines from
2-nitroaniline. Tetrahedron Lett 2015;56(48):6762–7.
[3] Karadeniz E, Zora M, Kılıçaslan NZ. Facile synthesis of aryl-substituted pyridines
via Suzuki-Miyaura approach. Tetrahedron 2015;71(47):8943–52.
[4] Kotha S, Ali R, Saifuddin M. Diversity-oriented approach to natural product
inspired pyrano-carbazole derivatives: strategic utilization of hetero-Diels–Alder
reaction, Fischer indolization and the Suzuki-Miyaura cross-coupling reaction.
Tetrahedron 2015;71(47):9003–11.
[5] Shahrestani N, Salahi F, Tavakoli N, Jadidi K, Hamzehloueian M, Notash B.
Asymmetric synthesis approach of enantiomerically pure spiro-indenoquinox-
aline pyrrolidines and spiro-indenoquinoxaline pyrrolizidines. Tetrahedron-
Asymmetr 2015;26(20):1117–29.
[6] Gajare VS, Khobare SR, Datrika R, Reddy KS, Rajana N, Kumar S, et al. Diversity
oriented concise asymmetric synthesis of azasugars: a facile access to l-2,3-
trans-3,4-cis-dihydroxyproline and (3S,5S)-3,4,5-trihydroxypiperidine. Tetrahe-
dron Lett 2015;56(48):6659–63.
[7] Wlochal J, Bailey A. Facile synthesis of 4-aryl and alkyl substituted, N6-alkylated
pyridazine-3,6-diamines. Tetrahedron Lett 2015;56(48):6791–4.
[8] Singla P, Luxami V, Paul K. Triazine as a promising scaold for its versatile
biological behavior. Eur J Med Chem 2015;102:39–57.
[9] Harmand L, Drabina P, Pejchal V, Husáková L, Sedlák M. Recyclable catalyst for
the asymmetric Henry reaction based on functionalized imidazolidine-4-one-
copper(II) complexes supported by a polystyrene copolymer. Tetrahedron Lett
2015;56(45):6240–3.
[10] Fang Z, He W, Cai M, Lin Y, Zhao H. A heterogeneous copper(I)-catalyzed aerobic
oxidative cross-dehydrogenative coupling of terminal alkynes with thiols
leading to alkynyl sulﬁdes. Tetrahedron Lett 2015;56(46):6463–7.
[11] Bhosale DS, Drabina P, Kincl M, Vlcˇek M, Sedlák M. Magnetically recoverable
catalyst for the asymmetric Henry reaction based on a substituted imidazo-
lidine-4-one copper(II) complex supported by Fe3O4SiO2 nanoparticles. Tetra-
hedron-Asymmetr 2015;26(21–22):1300–6.
[12] Ikeda M, Horio K, Tsuzuki T, Torii R, Shibata A, Kitamura Y, et al. New solid phase
submonomer synthesis of arylopeptoid oligomers using reductive amination.
Tetrahedron Lett 2015;56(48):6726–9.
[13] Mieczkowski A, Makowska M, Sekula J, Tomczyk E, Zalewska E, Nasulewicz-
Goldeman A, et al. Bicyclic cytarabine analogues: synthesis and investigation of
antitumor properties of novel, 6-aryl- and 6-alkyl-3H-pyrrolo[2,3-d]pyrimidin-2
(7H)-one arabinosides. Tetrahedron 2015;71(44):8454–61.
[14] Avilés E, Prudhomme J, Le Roch KG, Franzblau SG, Chandrasena K, Mayer AMS,
et al. Synthesis and preliminary biological evaluation of a small library of hybrid
compounds based on Ugi isocyanide multicomponent reactions with a marine
natural product scaold. Bioorg Med Chem Lett 2015;25(22):5339–43.
[15] Kung DW, Griﬃth DA, Esler WP, Vajdos FF, Mathiowetz AM, Doran SD, et al.
Discovery of spirocyclic-diamine inhibitors of mammalian acetyl CoA-carboxy-
lase. Bioorg Med Chem Lett 2015;25(22):5352–6.
[16] Chen Y, Cass SL, Kutty SK, Yee EMH, Chan DSH, Gardner CR, et al. Synthesis,
biological evaluation and structure–activity relationship studies of isoﬂavene
based Mannich bases with potent anti-cancer activity. Bioorg Med Chem Lett
2015;25(22):5377–83.
[17] Ling T, Tran M, González MA, Gautam LN, Connelly M, Wood RK, et al. (+)-
Dehydroabietylamine derivatives target triple-negative breast cancer. Eur J Med
Chem 2015;102:9–13.
[18] Majumdar P, Bathula C, Basu SM, Das SK, Agarwal R, Hati S, et al. Design,
synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I
(Top1) inhibitors with anticancer activity. Eur J Med Chem 2015;102:
540–51.
[19] Santos SA, Lukens AK, Coelho L, Nogueira F, Wirth DF, Mazitschek R, et al.
Exploring the 3-piperidin-4-yl-1H-indole scaold as a novel antimalarial chemo-
type. Eur J Med Chem 2015;102:320–33.
[20] Bluhm MEC, Knappe D, Homann R. Structure-activity relationship study using
peptide arrays to optimize Api137 for an increased antimicrobial activity against
Pseudomonas aeruginosa. Eur J Med Chem 2015;103:574–82.
[21] Doan N-G, de Molliens MP, Létourneau M, Fournier A, Chatenet D. Optimization
of on-resin palladium-catalyzed Sonogashira cross-coupling reaction for pep-
tides and its use in a structure–activity relationship study of a class B GPCR
ligand. Eur J Med Chem 2015;104:106–14.
4 N.K. Terrett / Combinatorial Chemistry - An Online Journal 18 (2016) 1–4Further reading
Papers with relevance to combinatorial chemistry or solid-phase
synthesis from other journals.
Berini C, Sebban M, Oulyadi H, Sanselme M, Levacher V, Briere J-F. Organocatalyzed
multicomponent synthesis of isoxazolidin-5-ones. Org Lett 2015;17(21):
5408–11.
Das S, Nag A, Liang J, Bunck DN, Umeda A, Farrow B, et al. A general synthetic
approach for designing epitope targeted macrocyclic peptide ligands. Angew
Chem Int Ed Engl 2015;54(45):13219–24.
Diagne AB, Li S, Perkowski GA, Mrksich M, Thomson RJ. SAMDI mass spectrometry-
enabled high-throughput optimization of a traceless Petasis reaction. ACS Comb
Sci 2015;17(11):658–62.
Fernicola S, Giardina G, Rinaldo S, Cutruzzola F, Torquati I, Del BF, et al. Synthesis of
triazole-linked analogues of c-di-GMP and their interactions with diguanylate
cyclase. J Med Chem 2015;58(20):8269–84.
Guasch L, Zakharov AV, Tarasova OA, Poroikov VV, Liao C, Nicklaus MC. Novel HIV-1
integrase inhibitor development by virtual screening based on QSAR models. Curr
Top Med Chem (Sharjah, United Arab Emirates) 2016;16(4):441–8.
Ivachtchenko AV, Yamanushkin PM, Mit’kin OD, Ezhova EV, Korzinov OM, Bulanova
EA, et al. New heterocyclic hepatitis C virus (HCV) inhibitors containing A 2-
aminomethyl-1H-indole fragment. Pharm Chem J 2015;49(6):352–61.
Krasavin M, Mujumdar P, Parchinsky V, Vinogradova T, Manicheva O, Dogonadze M.
Library of diversely substituted 2-(quinolin-4-yl)imidazolines delivers novel non-
cytotoxic antitubercular leads. J Enzyme Inhib Med Chem 2015;1–10.Kulchat S, Lehn J-M. Dynamic covalent chemistry of nucleophilic substitution
component exchange of quaternary ammonium salts. Chem Asian J 2015;10
(11):2484–96.
Lafuente M, Atcher J, Sola J, Alfonso I. Adaptive correction from virtually complex
dynamic libraries: The role of noncovalent interactions in structural selection and
folding. Chem Eur J 2015;21(47):17002–9.
Loh JK, Asad N, Samarakoon TB, Hanson PR. Modular, one-pot, sequential aziridine
ring opening-SNAr strategy to 7-, 10-, and 11-membered benzo-fused sultams. J
Org Chem 2015;80(20):9926–41.
Pinkin NK, Power AN, Waters ML. Late stage modiﬁcation of receptors identiﬁed from
dynamic combinatorial libraries. Org Biomol Chem 2015;13(44):10939–45.
Proulx C, Yoo S, Connolly MD, Zuckermann RN. Accelerated submonomer solid-phase
synthesis of peptoids incorporating multiple substituted N-aryl glycine mono-
mers. J Org Chem. 2015;80(21):10490–7.
Raghavan S, Manogaran P, Kalpattu Kuppuswami B, Venkatraman G, Gadepalli
Narasimha KK. Synthesis and anticancer activity of chalcones derived from
vanillin and isovanillin. Med Chem Res 2015;24(12):4157–65.
Sarac I, Meier C. Eﬃcient automated solid-phase synthesis of DNA and RNA 50-
triphosphates. Chemistry 2015;21(46):16421–6.
Schmittel M. From self-sorted coordination libraries to networking nanoswitches for
catalysis. Chem Commun (Cambridge, UK) 2015;51(81):14956–68.
Ulatowski F, Lichosyt D, Jurczak J. Introducing a static receptor to compete with a
dynamic combinatorial library in template binding. Org Biomol Chem 2015;13
(42):10451–5.
Yao G, Pan Z, Wu C, Wang W, Fang L, Su W. Eﬃcient synthesis and stereochemical
revision of coibamide A. J Am Chem Soc 2015;137(42):13488–91.
